Anastrozole as add-on therapy for cabergoline-resistant prolactin-secreting pituitary adenomas: real-life experience in male patients

INTRODUCTION: Prolactin-secreting adenoma (PRLoma) can present as large and invasive neoplasm, with increased markers of cellular proliferation. First-line approach is Dopamine Agonists (DAs) treatment; however, DA-resistance has been reported, especially in male patients. Estrogens induce lactotrop...

Descripción completa

Detalles Bibliográficos
Autores principales: Ceccato, Filippo, Lizzul, Laura, Voltan, Giacomo, Barbot, Mattia, Scaroni, Carla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550050/
https://www.ncbi.nlm.nih.gov/pubmed/34173929
http://dx.doi.org/10.1007/s11102-021-01165-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550050/
https://www.ncbi.nlm.nih.gov/pubmed/34173929
http://dx.doi.org/10.1007/s11102-021-01165-0

Ejemplares similares